Betaseron packages contain alcohol prep products. The Triad alcohol prep packages are potentially contaminated with the bacteria, Bacillus cereus, that could lead to life-threatening infections. According to Bayer, the maker of Betaseron, the Triad alcohol prep pads packaged for use in the U.S. with Betaseron should not be used by patients. There is NO involvement or potential contamination of the Betaseron vial or other components in the Betaseron U.S. packaging. This issue is confined to the actual Triad alcohol prep products. These prep packages are only in the U.S.
Bayer instructs patients using Betaseron to immediately discontinue using the Triad alcohol prep pads included in the Betaseron packaging and dispose of those pads in the trash. When preparing to take their Betaseron injection, patients should use an alternative alcohol prep pad that is not subject to this Triad recall or use a sterile gauze pad in conjunction with isopropyl alcohol.
Further information on this Triad recall can be found on the FDA website. If you have additional questions, please consult with your pharmacist or health care provider or contact BETAPLUS at 1-800-788-1467 option 1 to speak to a BETA Nurse. Or call Bayer at 1-888-84-BAYER, where operators will be available 24 hours a day to respond to questions from consumers or medical professionals.
What is Betaseron? BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
It is concerning that not only alcohol cannot stop the bacteria, but that this bacteria was present at the production facility of the Triad Alcohol Pads. To learn more about Bacillus cereus, check out Wikipedia.